{"id":"https://openalex.org/W2377458274","doi":null,"title":"Effect of Bortezomib on serum cystatin-C in multiple myeloma","display_name":"Effect of Bortezomib on serum cystatin-C in multiple myeloma","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2377458274","mag":"2377458274"},"language":"en","primary_location":{"id":"mag:2377458274","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-YYLC201102056.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764564064","display_name":"Practical Journal of Clinical Medicine","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361727549","host_organization_name":"Sichuan Medical Association","host_organization_lineage":["https://openalex.org/P4361727549"],"host_organization_lineage_names":["Sichuan Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Practical Journal of Clinical Medicine","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101160946","display_name":"Rong Xiao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Rong Xiao","raw_affiliation_strings":["Sichuan Provincial People's Hospital,Chengdu 610072,China)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sichuan Provincial People's Hospital,Chengdu 610072,China)","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5101160946"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.28657894,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cystatin-c","display_name":"cystatin C","score":0.9110000133514404},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9620000123977661},{"id":"https://openalex.org/keywords/beta2-microglobulin","display_name":"beta2-microglobulin","score":0.9750000238418579},{"id":"https://openalex.org/keywords/relapsed-multiple-myeloma","display_name":"relapsed multiple myeloma","score":0.859000027179718},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.7400000095367432},{"id":"https://openalex.org/keywords/proteasome-inhibitor-therapy","display_name":"proteasome inhibitor therapy","score":0.9089999794960022}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.9625954627990723},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.9314023852348328},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9245271682739258},{"id":"https://openalex.org/C21957315","wikidata":"https://www.wikidata.org/wiki/Q287896","display_name":"Beta-2 microglobulin","level":2,"score":0.874978244304657},{"id":"https://openalex.org/C2780412452","wikidata":"https://www.wikidata.org/wiki/Q4505907","display_name":"Cystatin","level":4,"score":0.5622797608375549},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48121169209480286},{"id":"https://openalex.org/C188758523","wikidata":"https://www.wikidata.org/wiki/Q6947334","display_name":"Myeloma protein","level":3,"score":0.45463767647743225},{"id":"https://openalex.org/C2779548226","wikidata":"https://www.wikidata.org/wiki/Q413243","display_name":"Cystatin C","level":3,"score":0.42245346307754517},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3938634991645813},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3688296675682068},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3298488259315491},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.07991737127304077}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2377458274","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-YYLC201102056.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764564064","display_name":"Practical Journal of Clinical Medicine","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361727549","host_organization_name":"Sichuan Medical Association","host_organization_lineage":["https://openalex.org/P4361727549"],"host_organization_lineage_names":["Sichuan Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Practical Journal of Clinical Medicine","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2393514552","https://openalex.org/W1965920305","https://openalex.org/W7096180897","https://openalex.org/W3031002471","https://openalex.org/W2563593838","https://openalex.org/W2363167133","https://openalex.org/W4396673619","https://openalex.org/W3029968644","https://openalex.org/W2389710046","https://openalex.org/W3201600285"],"abstract_inverted_index":{"Objective":[0],"The":[1],"aim":[2],"of":[3,11,61,90],"this":[4],"study":[5],"was":[6],"to":[7,84],"assess":[8],"the":[9,74,81],"effect":[10],"Bortezomib":[12,56,70],"on":[13],"serum":[14,27],"cystatin-C(Cys-C)in":[15],"multiple":[16,32,91],"myeloma":[17,33,43,92],"and":[18,29,35,48,63],"whether":[19],"Cys-C":[20,28,47,75],"can":[21,71,77],"monitor":[22,85],"tumor":[23,86],"load.Methods":[24],"We":[25],"measured":[26],"\u03b22-microglobulin":[30,49,88],"in":[31,65],"patients":[34,44],"20":[36],"healthy":[37,53],"controls":[38],"pre-and":[39],"post-Bortezomib":[40],"therapy.Results":[41],"Multiple":[42],"had":[45],"higher":[46],"levels":[50,89],"compared":[51],"with":[52,55,69],"controls(P0.05).Treatment":[54],"produced":[57],"a":[58],"significant":[59],"reduction":[60],"cystatin-C":[62],"\u03b22-microglobulin,mainly":[64],"relapsed":[66],"patients(P0.05).Conclusion":[67],"Treatment":[68],"significantly":[72],"reduce":[73],"levels,which":[76],"be":[78],"regarded":[79],"as":[80],"potential":[82],"indicator":[83],"load,and":[87],"patients.":[93]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-06-24T00:00:00"}